Sequential Intravesical Gemcitabine and Docetaxel for the Salvage Treatment of Non-Muscle Invasive Bladder Cancer
Abstract Background: Bacillus Calmette-Guerin (BCG) is the most effective intravesical therapy for non-muscle invasive bladder cancer (NMIBC), but patients can fail or supply shortages can develop. For BCG failures, radical cystectomy is recommended. However, in patients who desire bladder preservat...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publishing
2015-04-01
|
| Col·lecció: | Bladder Cancer |
| Accés en línia: | https://doi.org/10.3233/BLC-150008 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|